Shareholder Information

Shares Issued

The number of shares in issue is 95,816,866.

Significant Shareholders

 

ShareholderNo. of ordinary shares% of issued share capital
Maven Income and Growth VCT110,611,86411.08%
Downing 1 VCT plc210,611,86411.08%
Santi – 1990 SL10,386,18210.84%
Chelverton Asset Management5,681,8185.93%
Octopus Investments 4,545,4554.74%
Equipos Medicos-Biologicos SA3,574,0003.73%
Sonia Rodriguez Clemente3,150,0003.29

held via Maven Income and Growth plc, Maven Income and Growth VCT 3 plc, Maven Income and Growth VCT 4 plc and Maven Income and Growth VCT 5 plc
2 held via Downing 1 VCT plc and Downing 4 VCT plc.

Director Shareholdings

DirectorNo. of ordinary shares% of issued share capital
Jordi Puig1,214,482,50015.11%
Matthew Walls10,762,50011.23%
Sergio Olivero23,574,0003.73%
David Evans3,317,0003.46%

1Aggregated with the interests of his wife, Sonia Rodriguez Clemente who holds 3,150,000 Ordinary Shares

2Jordi Puig and Sergio Olivero entered into an option agreement whereby Jordi Puig could call for the transfer of some or all of the Ordinary Shares in the capital of the Company held by Equipos Medico Biologicos S.A. Jordi Puig is therefore treated as being interested in such shares

* Paul Foulger’s wife, Laura Deegan, holds 568,182 shares in the Company representing 0.59% of the Company

Shares not in public hands

Insofar as it is aware, 62.05% of the Company's securities is not in public hands.

Statement of the Rights of Shareholders

The rights of shareholders are governed by UK law.

Restrictions in transfer of AIM securities

There are no restrictions on the transfer of the Company's ordinary shares.

UK City Code on Takeovers and Mergers

The Company is subject to the provisions of the City Code on Takeover and Mergers.

Other exchanges and trading platforms

GENinCode has not applied or agreed to have any of its securities admitted or traded on any other exchanges or trading platforms.

Page last updated: 22 July 2021

Latest Share Price

-
-
-

Latest News

Financial Calendar

Interim Results 16 September 2021

Board

Who Are We

Governance

Investor Alerts

GENinCode UK Limited
Oxford Science Park
John Eccles House
Robert Robinson Avenue
Oxford - UK
OX4 4GP
(+44) 186 5955 847
GENinCode S.L.U.
Rambla Egara, 235, ES- 08224
Terrassa-Barcelona
Spain
(+34) 936 690 321